These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Site-directed mutagenesis of the rat beta1-adrenoceptor. Involvement of Tyr356 (7.43) in (+/-)cyanopindolol but not (+/-)[125Iodo]cyanopindolol binding. Rezmann-Vitti LA; Louis SN; Nero TL; Jackman GP; Machida CA; Louis WJ Eur J Med Chem; 2004 Jul; 39(7):625-31. PubMed ID: 15236843 [TBL] [Abstract][Full Text] [Related]
6. Crystal structures of a stabilized β1-adrenoceptor bound to the biased agonists bucindolol and carvedilol. Warne T; Edwards PC; Leslie AG; Tate CG Structure; 2012 May; 20(5):841-9. PubMed ID: 22579251 [TBL] [Abstract][Full Text] [Related]
7. The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptor. Baker JG; Proudman RG; Tate CG Naunyn Schmiedebergs Arch Pharmacol; 2011 Jul; 384(1):71-91. PubMed ID: 21547538 [TBL] [Abstract][Full Text] [Related]
8. Structural insights into conformational stability of wild-type and mutant beta1-adrenergic receptor. Balaraman GS; Bhattacharya S; Vaidehi N Biophys J; 2010 Jul; 99(2):568-77. PubMed ID: 20643076 [TBL] [Abstract][Full Text] [Related]
9. Two distinct conformations of helix 6 observed in antagonist-bound structures of a beta1-adrenergic receptor. Moukhametzianov R; Warne T; Edwards PC; Serrano-Vega MJ; Leslie AG; Tate CG; Schertler GF Proc Natl Acad Sci U S A; 2011 May; 108(20):8228-32. PubMed ID: 21540331 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological Analysis and Structure Determination of 7-Methylcyanopindolol-Bound β1-Adrenergic Receptor. Sato T; Baker J; Warne T; Brown GA; Leslie AG; Congreve M; Tate CG Mol Pharmacol; 2015 Dec; 88(6):1024-34. PubMed ID: 26385885 [TBL] [Abstract][Full Text] [Related]
12. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study. Kooistra AJ; Leurs R; de Esch IJ; de Graaf C J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966 [TBL] [Abstract][Full Text] [Related]
13. FoldGPCR: structure prediction protocol for the transmembrane domain of G protein-coupled receptors from class A. Michino M; Chen J; Stevens RC; Brooks CL Proteins; 2010 Aug; 78(10):2189-201. PubMed ID: 20544957 [TBL] [Abstract][Full Text] [Related]
14. Identification of binding sites of bopindolol and its two metabolites with beta1-adrenoceptors by molecular modeling: comparison with beta2 adrenoceptors. Hattori K; Ishiguro M; Ohnuki T; Nakamura T; Muramatsu I; Nagatomo T Pharmacology; 1999 Apr; 58(4):183-9. PubMed ID: 10077737 [TBL] [Abstract][Full Text] [Related]
16. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors. Emtage AL; Mistry SN; Fischer PM; Kellam B; Laughton CA J Biomol Struct Dyn; 2017 Sep; 35(12):2604-2619. PubMed ID: 27532213 [TBL] [Abstract][Full Text] [Related]
17. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes. Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579 [TBL] [Abstract][Full Text] [Related]
18. Mutagenesis within helix 6 of the human beta1-adrenergic receptor identifies Lysine324 as a residue involved in imparting the high-affinity binding state of agonists. Zeitoun O; Santos NM; Gardner LA; White SW; Bahouth SW Mol Pharmacol; 2006 Sep; 70(3):838-50. PubMed ID: 16760361 [TBL] [Abstract][Full Text] [Related]
19. Ligand entry and exit pathways in the beta2-adrenergic receptor. Wang T; Duan Y J Mol Biol; 2009 Oct; 392(4):1102-15. PubMed ID: 19665031 [TBL] [Abstract][Full Text] [Related]